Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology company focused on developing and commercializing innovative protein-based vaccines to combat serious infectious diseases, ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to ...

SINGAPORE – Two updated Covid-19 vaccines will be rolled out from Oct 28 at almost 500 clinics and 10 polyclinics, with the five remaining Joint Testing and Vaccination Centres (JTVCs ...

About a week later, the agency authorized an updated version of Novavax’s protein subunit vaccine for people 12 years and older. The mRNA vaccines specifically target KP.2, a subvariant of JN.

As of 2022, only around 24 percent of adults had reported ever getting a pneumococcal vaccine, according to the C.D.C. Doctors have long observed stark racial disparities in who pneumococcal ...

Dr. Marty discusses why the FDA put a hold on the Novavax COVID-Flu vaccines and how their COVID vaccine is different from the others that are offered. She also explains the possible connections ...

Vaccines help countries with fewer resources protect themselves from disease. Outbreaks disproportionately affect poorer areas: the 2014–2016 Ebola epidemic in West Africa, for example ...